Berchuck A - Search Results

1

Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.

Lancaster JM, Cochran CJ, Brownlee HA, Evans AC, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: berchuck a. J Natl Cancer Inst. 1996 Apr 17;88(8):552-4. doi: 10.1093/jnci/88.8.552. J Natl Cancer Inst. 1996. PMID: 8606385 No abstract available.

2

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

3

Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma.

Berchuck A, Anspach C, Evans AC, Soper JT, Rodriguez GC, Dodge R, Robboy S, Clarke-Pearson DL. Berchuck A, et al. Gynecol Oncol. 1995 Oct;59(1):20-4. doi: 10.1006/gyno.1995.1262. Gynecol Oncol. 1995. PMID: 7557610 Clinical Trial.

4

Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.

Risinger JI, Umar A, Boyer JC, Evans AC, Berchuck A, Kunkel TA, Barrett JC. Risinger JI, et al. Among authors: berchuck a. Cancer Res. 1995 Dec 1;55(23):5664-9. Cancer Res. 1995. PMID: 7585651

5

Evaluation of prognostic factors and staging in gestational trophoblastic tumor.

Soper JT, Evans AC, Conaway MR, Clarke-Pearson DL, Berchuck A, Hammond CB. Soper JT, et al. Among authors: berchuck a. Obstet Gynecol. 1994 Dec;84(6):969-73. Obstet Gynecol. 1994. PMID: 7970479

6

A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.

Jacobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, Leech V, Molyneux A, Berchuck A, Ponder BA, et al. Jacobs IJ, et al. Among authors: berchuck a. Cancer Res. 1993 Mar 15;53(6):1218-21. Cancer Res. 1993. PMID: 8095178

7

The p53 tumor suppressor gene frequently is altered in gynecologic cancers.

Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):246-52. doi: 10.1016/s0002-9378(94)70414-7. Am J Obstet Gynecol. 1994. PMID: 8296829 Review.

8

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A. Kohler MF, et al. Among authors: berchuck a. J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9. doi: 10.1093/jnci/85.18.1513. J Natl Cancer Inst. 1993. PMID: 8360934

9

An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene.

Lancaster JM, Wiseman RW, Berchuck A. Lancaster JM, et al. Among authors: berchuck a. Obstet Gynecol. 1996 Feb;87(2):306-9. doi: 10.1016/0029-7844(95)00405-X. Obstet Gynecol. 1996. PMID: 8559544

10

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: berchuck a. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters